BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17466983)

  • 1. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C virus and its susceptibility to interferon.
    Hiraga N; Imamura M; Tsuge M; Noguchi C; Takahashi S; Iwao E; Fujimoto Y; Abe H; Maekawa T; Ochi H; Tateno C; Yoshizato K; Sakai A; Sakai Y; Honda M; Kaneko S; Wakita T; Chayama K
    FEBS Lett; 2007 May; 581(10):1983-7. PubMed ID: 17466983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes.
    Aly HH; Watashi K; Hijikata M; Kaneko H; Takada Y; Egawa H; Uemoto S; Shimotohno K
    J Hepatol; 2007 Jan; 46(1):26-36. PubMed ID: 17112629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon.
    Boulestin A; Kamar N; Sandres-Sauné K; Legrand-Abravanel F; Alric L; Vinel JP; Rostaing L; Izopet J
    J Med Virol; 2006 Mar; 78(3):365-71. PubMed ID: 16419107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of viral interference and different susceptibility to interferon between hepatitis B virus and hepatitis C virus in human hepatocyte chimeric mice.
    Hiraga N; Imamura M; Hatakeyama T; Kitamura S; Mitsui F; Tanaka S; Tsuge M; Takahashi S; Abe H; Maekawa T; Ochi H; Tateno C; Yoshizato K; Wakita T; Chayama K
    J Hepatol; 2009 Dec; 51(6):1046-54. PubMed ID: 19853955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
    Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
    Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in viral kinetics between genotypes 1 and 2 of hepatitis C virus after single administration of standard interferon-alpha.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Atsumi H; Takagi M; Nakano S; Arakawa T; Fujimori M
    J Med Virol; 2009 Aug; 81(8):1354-62. PubMed ID: 19551828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of an infectious genotype 1b hepatitis C virus clone in human hepatocyte chimeric mice.
    Kimura T; Imamura M; Hiraga N; Hatakeyama T; Miki D; Noguchi C; Mori N; Tsuge M; Takahashi S; Fujimoto Y; Iwao E; Ochi H; Abe H; Maekawa T; Arataki K; Tateno C; Yoshizato K; Wakita T; Okamoto T; Matsuura Y; Chayama K
    J Gen Virol; 2008 Sep; 89(Pt 9):2108-2113. PubMed ID: 18753219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus.
    Tsuge M; Hiraga N; Takaishi H; Noguchi C; Oga H; Imamura M; Takahashi S; Iwao E; Fujimoto Y; Ochi H; Chayama K; Tateno C; Yoshizato K
    Hepatology; 2005 Nov; 42(5):1046-54. PubMed ID: 16250045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras.
    Yanagi M; Purcell RH; Emerson SU; Bukh J
    Virology; 1999 Sep; 262(1):250-63. PubMed ID: 10489358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus infection in human liver tissue engrafted in mice with an infectious molecular clone.
    Maeda N; Watanabe M; Okamoto S; Kanai T; Yamada T; Hata J; Hozumi N; Katsume A; Nuriya H; Sandhu J; Ishii H; Kohara M; Hibi T
    Liver Int; 2004 Jun; 24(3):259-67. PubMed ID: 15189278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
    Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary hepatocyte culture supports hepatitis C virus replication: a model for infection-associated hepatocarcinogenesis.
    Banaudha K; Orenstein JM; Korolnek T; St Laurent GC; Wakita T; Kumar A
    Hepatology; 2010 Jun; 51(6):1922-32. PubMed ID: 20512986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6-mediated intersubgenotypic variation of interferon sensitivity in hepatitis C virus genotype 2a/2b chimeric clones.
    Suda G; Sakamoto N; Itsui Y; Nakagawa M; Tasaka-Fujita M; Funaoka Y; Watanabe T; Nitta S; Kiyohashi K; Azuma S; Kakinuma S; Tsuchiya K; Imamura M; Hiraga N; Chayama K; Watanabe M
    Virology; 2010 Nov; 407(1):80-90. PubMed ID: 20797756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.
    Murao K; Imachi H; Yu X; Cao WM; Nishiuchi T; Chen K; Li J; Ahmed RA; Wong NC; Ishida T
    Gut; 2008 May; 57(5):664-71. PubMed ID: 17998316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical evaluation of a mouse with chimeric human liver model for hepatitis C virus infection using an NS3-4A protease inhibitor.
    Kamiya N; Iwao E; Hiraga N; Tsuge M; Imamura M; Takahashi S; Miyoshi S; Tateno C; Yoshizato K; Chayama K
    J Gen Virol; 2010 Jul; 91(Pt 7):1668-77. PubMed ID: 20164258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus replication in mice with chimeric human livers.
    Mercer DF; Schiller DE; Elliott JF; Douglas DN; Hao C; Rinfret A; Addison WR; Fischer KP; Churchill TA; Lakey JR; Tyrrell DL; Kneteman NM
    Nat Med; 2001 Aug; 7(8):927-33. PubMed ID: 11479625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization.
    Scheel TK; Gottwein JM; Jensen TB; Prentoe JC; Hoegh AM; Alter HJ; Eugen-Olsen J; Bukh J
    Proc Natl Acad Sci U S A; 2008 Jan; 105(3):997-1002. PubMed ID: 18195353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections.
    Kosaka K; Hiraga N; Imamura M; Yoshimi S; Murakami E; Nakahara T; Honda Y; Ono A; Kawaoka T; Tsuge M; Abe H; Hayes CN; Miki D; Aikata H; Ochi H; Ishida Y; Tateno C; Yoshizato K; Sasaki T; Chayama K
    Biochem Biophys Res Commun; 2013 Nov; 441(1):230-5. PubMed ID: 24140055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection of common marmosets with hepatitis C virus/GB virus-B chimeras.
    Li T; Zhu S; Shuai L; Xu Y; Yin S; Bian Y; Wang Y; Zuo B; Wang W; Zhao S; Zhang L; Zhang J; Gao GF; Allain JP; Li C
    Hepatology; 2014 Mar; 59(3):789-802. PubMed ID: 24123143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
    Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
    Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.